Agency Forms Undergoing Paperwork Reduction Act Review, 4165-4166 [2014-01409]
Download as PDF
Federal Register / Vol. 79, No. 16 / Friday, January 24, 2014 / Notices
technology to minimize the information
collection burden.
Darius Taylor,
Deputy, Information Collection Clearance
Officer.
[FR Doc. 2014–01415 Filed 1–23–14; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on HIV/AIDS
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Service (DHHS) is hereby giving notice
that the Presidential Advisory Council
on HIV/AIDS (PACHA) will hold a
meeting; the primary topic of discussion
will be the Ryan White Program. The
meeting will be open to the public.
DATES: The meeting will be held on
February 27, 2014 from 9 a.m. to
approximately 3 p.m. (EDT) and
February 28, 2014 from 9 a.m. to
approximately 12:30 p.m. (EDT).
ADDRESSES: U.S. Department of Health
and Human Services, 200 Independence
Avenue SW., Washington, DC 20201 in
the Auditorium on February 27 and in
the John M. Eisenberg Memorial Room
(The Penthouse) on February 28, 2014.
FOR FURTHER INFORMATION CONTACT: Ms.
Caroline Talev, Public Health Analyst,
Presidential Advisory Council on HIV/
AIDS, U.S. Department of Health and
Human Services, 200 Independence
Avenue SW., Room 443H, Washington,
DC 20201; (202) 205–1178. More
detailed information about PACHA can
be obtained by accessing the Council’s
Web site www.aids.gov/pacha.
SUPPLEMENTARY INFORMATION: PACHA
was established by Executive Order
12963, dated June 14, 1995 as amended
by Executive Order 13009, dated June
14, 1996. The Council was established
to provide advice, information, and
recommendations to the Secretary
regarding programs and policies
intended to promote effective
prevention of HIV disease and AIDS.
The functions of the Council are solely
advisory in nature.
The Council consists of not more than
25 members. Council members are
selected from prominent community
TKELLEY on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:22 Jan 23, 2014
Jkt 232001
leaders with particular expertise in, or
knowledge of, matters concerning HIV
and AIDS, public health, global health,
philanthropy, marketing or business, as
well as other national leaders held in
high esteem from other sectors of
society. Council members are appointed
by the Secretary or designee, in
consultation with the White House
Office on National AIDS Policy. The
agenda for the upcoming meeting will
be posted on the Council’s Web site at
www.aids.gov/pacha.
Public attendance at the meeting is
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
designated contact person. Due to space
constraints, pre-registration for public
attendance is advisable and can be
accomplished by contacting Caroline
Talev at caroline.talev@hhs.gov by close
of business Wednesday, February 12,
2014. Members of the public will have
the opportunity to provide comments at
the meeting. Any individual who
wishes to participate in the public
comment session must register with
Caroline Talev at caroline.talev@hhs.gov
by close of business Wednesday,
February 12, 2014; registration for
public comment will not be accepted by
telephone. Individuals are encouraged
to provide a written statement of any
public comment(s) for accurate minute
taking purposes. Public comment will
be limited to two minutes per speaker.
Any members of the public who wish to
have printed material distributed to
PACHA members at the meeting should
submit, at a minimum, 1 copy of the
material(s) to Caroline Talev, no later
than close of business February 12,
2014.
Dated: January 9, 2014.
B. Kaye Hayes,
Executive Director, Presidential Advisory
Council on HIV/AIDS.
[FR Doc. 2014–01360 Filed 1–23–14; 8:45 am]
BILLING CODE 4150–43–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–14–0881]
Agency Forms Undergoing Paperwork
Reduction Act Review
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Data Calls for the Laboratory
Response Network—Extension—(OMB
No. 0920–0881, expires 3/31/14)—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Laboratory Response Network
(LRN) was established by the
Department of Health and Human
Services, Centers for Disease Control
and Prevention (CDC) in accordance
with Presidential Decision Directive 39,
which outlined national anti-terrorism
policies and assigned specific missions
to Federal departments and agencies.
The LRN’s mission is to maintain an
integrated national and international
network of laboratories that can respond
to acts of biological, chemical, or
radiological terrorism and other public
health emergencies. Federal, State, and
local public health laboratories
voluntarily join the LRN.
The LRN Program Office maintains a
database of information for each
member laboratory that includes contact
information as well as staff and
equipment inventories. However,
semiannually or during emergency
response, the LRN Program Office may
conduct a Special Data Call to obtain
additional information from LRN
Member Laboratories in regards to
biological or chemical terrorism
preparedness. Special Data Calls may be
conducted via queries that are
distributed by broadcast emails or by
survey tools (i.e. Survey Monkey). This
is a request for an extension to this
generic clearance. The only cost to
respondents is their time to respond to
the data call. The total annual burden
hours requested is 400 hours.
The Centers for Disease Control and
Prevention (CDC) publishes a list of
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
4165
E:\FR\FM\24JAN1.SGM
24JAN1
4166
Federal Register / Vol. 79, No. 16 / Friday, January 24, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents
No. of responses
per respondent
No. of
respondents
Form name
Avg. Burden per
response
(in hrs.)
4
30/60
Public Health Laboratorians .............................
Special Data Call
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
2014. If you have never attended a
Connect Pro event before, test your
connection at https://
collaboration.fda.gov/common/help/en/
FOR FURTHER INFORMATION CONTACT:
support/meeting_test.htm. To get a
Geetha Jayan, Center for Devices and
quick overview of the Connect Pro
Radiological Health, Food and Drug
program, visit https://www.adobe.com/
Administration, 10903 New Hampshire
go/connectpro_overview. (FDA has
Ave., Bldg. 66, rm. 3622, Silver Spring,
verified the Web site addresses in this
MD 20903–0002, 301–796–6300, email:
document, but FDA is not responsible
geetha.jayan@fda.hhs.gov.
for any subsequent changes to the Web
SUPPLEMENTARY INFORMATION:
sites after this document publishes in
Registration: Registration is free and
the Federal Register.)
available on a first-come, first-served
Comments: FDA is holding this public
basis. Persons interested in attending
workshop to obtain information on
this public workshop must register
biofilms and anti-biofilm technology on
online by 5 p.m. February 7, 2014. Early medical devices. In order to permit the
registration is recommended because
widest possible opportunity to obtain
facilities are limited and, therefore, FDA public comment, FDA is soliciting
may limit the number of participants
either electronic or written comments
from each organization. If time and
on all aspects of the public workshop
space permit, onsite registration on the
topics. The deadline for submitting
day of the public workshop will be
comments related to this public
provided beginning at 7 a.m.
workshop is March 20, 2014.
If you need special accommodations
Regardless of attendance at the public
due to a disability, please contact Susan workshop, interested persons may
Monahan, (email: susan.monahan@
submit either electronic comments
fda.hhs.gov or phone: 301–796–5661) no regarding this document to https://
later than February 7, 2014.
www.regulations.gov or written
To register for the public workshop,
comments to the Division of Dockets
please visit FDA’s Medical Devices
Management (HFA–305), Food and Drug
News & Events—Workshops &
Administration, 5630 Fishers Lane, rm.
Conferences calendar at https://
1061, Rockville, MD 20852. It is only
www.fda.gov/MedicalDevices/
necessary to send one set of comments.
NewsEvents/WorkshopsConferences/
Identify comments with the docket
default.htm. (Select this public
number found in brackets in the
workshop from the posted events list.)
heading of this document. In addition,
Please provide complete contact
when responding to specific questions
information for each attendee, including as outlined in section II, please identify
name, title, affiliation, email, and
the question you are addressing.
telephone number. Those without
Received comments may be seen in the
Internet access should contact Susan
Division of Dockets Management
Monahan to register. Registrants will
between 9 a.m. and 4 p.m., Monday
receive confirmation after they have
through Friday and will be posted to the
been accepted. You will be notified if
docket at https://www.regulations.gov.
Transcripts: Please be advised that as
you are on a waiting list.
soon as a transcript is available, it will
Streaming Webcast of the Public
be accessible at https://
Workshop: This public workshop will
www.regulations.gov. It may be viewed
also be Webcast. Persons interested in
at the Division of Dockets Management
viewing the Webcast must register
(see Comments). A transcript will also
online by 5 p.m. (EST) on February 6,
2014. Early registration is recommended be available in either hardcopy or on
CD–ROM, after submission of a
because Webcast connections are
Freedom of Information request. Written
limited. Organizations are requested to
requests are to be sent to the Division
register all participants, but to view
of Freedom of Information (ELEM–
using one connection per location.
1029), Food and Drug Administration,
Webcast participants will be sent
12420 Parklawn Dr., Element Bldg.,
technical system requirements after
registration and will be sent connection Rockville, MD 20857. A link to the
transcripts will also be available
access information after February 14,
[FR Doc. 2014–01409 Filed 1–23–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–0056]
Biofilms, Medical Devices, and AntiBiofilm Technology—Challenges and
Opportunities; Public Workshop;
Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice of public workshop;
request for comments.
ACTION:
The Food and Drug Administration
(FDA) is announcing the following
public workshop entitled ‘‘Biofilms,
Medical Devices, and Anti-Biofilm
Technology—Challenges and
Opportunities.’’ FDA is cosponsoring
this workshop with the Center for
Biofilm Engineering of Montana State
University. The purpose of the public
workshop is to initiate dialogue between
academia, industry, and U.S.
Government scientists on the science of
developing products to address biofilm
formation. Topics of discussion include
current scientific and medical research
on biofilms, their impact on medical
devices, and biofilm prevention
strategies and their public health
impact.
The public workshop will be
held on February 20, 2014, from 8 a.m.
to 5 p.m.
ADDRESSES: The public workshop will
be held at FDA’s White Oak Campus,
10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (rm.
1503A), Silver Spring, MD 20993–0002.
Entrance for the public workshop
participants (non-FDA employees) is
through Building 1 where routine
security check procedures will be
performed. For parking and security
information, please refer to https://
www.fda.gov/AboutFDA/
TKELLEY on DSK3SPTVN1PROD with NOTICES
DATES:
VerDate Mar<15>2010
16:22 Jan 23, 2014
Jkt 232001
200
WorkingatFDA/BuildingsandFacilities/
WhiteOakCampusInformation/
ucm241740.htm.
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
E:\FR\FM\24JAN1.SGM
24JAN1
Agencies
[Federal Register Volume 79, Number 16 (Friday, January 24, 2014)]
[Notices]
[Pages 4165-4166]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-01409]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-14-0881]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
(404) 639-7570 or send an email to omb@cdc.gov. Send written comments
to CDC Desk Officer, Office of Management and Budget, Washington, DC
20503 or by fax to (202) 395-5806. Written comments should be received
within 30 days of this notice.
Proposed Project
Data Calls for the Laboratory Response Network--Extension--(OMB No.
0920-0881, expires 3/31/14)--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Laboratory Response Network (LRN) was established by the
Department of Health and Human Services, Centers for Disease Control
and Prevention (CDC) in accordance with Presidential Decision Directive
39, which outlined national anti-terrorism policies and assigned
specific missions to Federal departments and agencies. The LRN's
mission is to maintain an integrated national and international network
of laboratories that can respond to acts of biological, chemical, or
radiological terrorism and other public health emergencies. Federal,
State, and local public health laboratories voluntarily join the LRN.
The LRN Program Office maintains a database of information for each
member laboratory that includes contact information as well as staff
and equipment inventories. However, semiannually or during emergency
response, the LRN Program Office may conduct a Special Data Call to
obtain additional information from LRN Member Laboratories in regards
to biological or chemical terrorism preparedness. Special Data Calls
may be conducted via queries that are distributed by broadcast emails
or by survey tools (i.e. Survey Monkey). This is a request for an
extension to this generic clearance. The only cost to respondents is
their time to respond to the data call. The total annual burden hours
requested is 400 hours.
[[Page 4166]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Avg. Burden per
Type of respondents Form name No. of No. of responses response (in
respondents per respondent hrs.)
----------------------------------------------------------------------------------------------------------------
Public Health Laboratorians........ Special Data Call 200 4 30/60
----------------------------------------------------------------------------------------------------------------
Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-01409 Filed 1-23-14; 8:45 am]
BILLING CODE 4163-18-P